Tumor necrosis factor receptor 2 microsatellite and exon 6 polymorphisms in rheumatoid arthritis in Taiwan

Journal of Rheumatology

Volumn 30, Issue 3, 2003, Pages 438-442

  Yen, Jeng Hsien ^a,d   Tsai, Wen Chan ^a   Chen, Chung Jen ^a   Ou, Tsan Teng ^b   Lin, Chia Hui ^a   Hu, Chaur Jong ^c   Liu, Hong Wen ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c JEN AI HOSPITAL   (Taiwan)

^d KAOHSIUNG MUNICIPAL UNITED HOSPITAL   (Taiwan)

Author keywords

Microsatellite; Polymorphism; Rheumatoid arthritis; Tumor necrosis factor receptor

Indexed keywords

HLA DR4 ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALLELE; ARTICLE; BONE EROSION; CONTROLLED STUDY; ELECTROPHORESIS; EXON; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SJOEGREN SYNDROME; TAIWAN;

ANTIGENS, CD; ARTHRITIS, RHEUMATOID; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROSATELLITE REPEATS; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TAIWAN;

EID: 0037334395     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. McCusker CT, Singal DP. Molecular relationships between the class II HLA antigens and susceptibility to rheumatoid arthritis. J Rheumatol 1988;15:1050-3.
2. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
3. Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW. HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan, J Rheumatol 1995;22:1450-4.
4. Shiozawa S, Hayashi S, Tsukamoto Y, et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 1998;10:1891-5.
5. Cornelis F, Faure S, Martinez M, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998;95:10746-50.
6. Baker E, Chen LZ, Smith CA, Callen DF, Goodwin R, Sutherland GR. Chromosomal location of the human tumor necrosis factor receptor genes. Cytogenet Cell Genet 1991;57:117-8.
7. Kemper O, Derre J, Cherif D, Engelmann H, Wallach D, Berger R. The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3. Hum Genet 1991;87:623-4.
8. Husby G, Williams RC Jr. Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis. J Autoimmun 1988;1:363-71.
9. Yen JH, Chen CJ, Tsai WC, et al. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 2001;28:1788-92.
10. Hohmann HP, Remy R, Brockhaus M, van Loon APGM. Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J Biol Chem 1989;264:14927-34.
11. Loetscher H, Stueber D, Banner D, Mackay F, Lesslauer W. Human necrosis factor alpha mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem 1993;268:26350-7.
12. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of human necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990;87:3127-31.
13. Santee SM, Owen-Schaub LB. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J Biol Chem 1996;271:21151-9.
14. Rau H, Donner H, Usadel KH, Badenhoop K. Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves' disease. Tissue Antigen 1997;49:535-6.
15. Shibue T, Tsuchiya N, Komata T, et al. Tumor necrosis factor α 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 2000;43:753-7.
16. Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999;53:527-33.
17. Takahashi M, Hashimoto H, Akizuki M, et al. Lack of association between the Met196Arg polymorphism in the TNFR2 gene and autoimmune diseases accompanied by vasculitis including SLE in Japanese. Tissue Antigens 2001;57:66-9.
18. Al-Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 2000;55:97-9.
19. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18-27.
20. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;20:251-3.
21. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1955;20:309-11.
22. Beltinger CP, White PS, Maris JM, et al. Physical mapping and genomic structure of the human TNFR2 gene. Genomics 1996;35:94-100.
23. Heilig B, Mapara M, Brockhaus M, Krauth K, Dorken B. Two types of TNF receptors are expressed on human normal and malignant B lymphocytes. Clin Immunol Immunopath 1991;61:260-7.
24. Erickson SL, de Sauvage FJ, Kikly K, et al. Decreased sensitivity to tumor-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994;372:560-3.
25. Abe Y, Yamauchi K, Kimura S. 75- but not 55-kDa tumor necrosis factor receptor is active in the homotypic aggregation and proliferation of human lymphokine-activated T killer (T-LAK) cells in vitro. J Leukoc Biol 1995;57:462-8.
26. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995;377:348-51.
27. Trentin L, Zambello R, Bulian P, et al. Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor. Br J Cancer 1995;71:240-5.
28. Mason AT, McVicar RD, Smith CA, Young HA, Ware CF, Ortaldo JR. Regulation of NK cells through the 80-kDa TNFR (CD120b). J Leukoc Biol 1995;58:249-55.
29. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol 1992;149:911-7.
30. Vandenabeele P, Declercq W, Vercammen D, Van de Craen M, Grooten J, Fiers W. Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma. J Exp Med 1992;176:1015-24.
31. Jacobsen FW, Rothe M, Rusten L, et al. Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis. Proc Natl Acad Sci USA 1994;91:10695-9.
32. Bemelmans MHA, Gouma DJ, Buurman WA. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 1993;150:2007-17.
33. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 1995;154:2904-13.
34. Roux-Lombard P, Punzi L, Hasler F, et al. Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1993;36:485-9.
35. Heller RA, Song K, Onasch MA, Fischer WH, Chang D, Ringold GM. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci USA 1990;87:6151-5.
36. Kohno T, Brewer MT, Baker SL, et al. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 1990;87:8331-5.
37. Heilig B, Wermann M, Gallati H, et al. Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Invest 1992;70:22-7.
38. Olsson I, Gatanaga T, Gullberg U, Lantz M, Granger GA. Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw 1993;4:169-80.
39. Aderka D, Wysenbeek A, Engelmann H, et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993;36:1111-20.
40. Digel W, Porzsolt F, Schmid M, Hermann F, Lesslauer W, Brockhaus M. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J Clin Invest 1992;89:1690-3.
41. Gattorno M, Picco P, Buoncompagni A, Stalla F, Pistoia V. Tumor necrosis factor receptor p75 correlates better than p55 with disease activity in juvenile rheumatoid arthritis: comment on the article by Mangge et al [letter]. Arthritis Rheum 1996;39:883-4.
42. Heilig B, Fiehn C, Brockhaus M, Gallati H, Pezzutto A, Hunstein W. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematous, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 1993;13:321-8.
43. Cope AP, Aderka D, Doherty M, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-9.
44. Bloomfield CD, Garson OM, Volin L, Knuutila S, de la Chapelle A. t(1;3)(p36;q21) in acute nonlymphocytic leukemia: a new cytogenetic-clinicopathologic association. Blood 1985;66:1409-13.
45. Yamada K, Sugimoto E, Amano M, Imamura Y, Kubota T, Matsumoto M. Two cases of acute promyelocytic leukemia with variant translocations: the importance of chromosome No. 17 abnormality. Cancer Genet Cytogenet 1983;9:93-9.
46. White PS, Maris JM, Beltinger C, et al. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 1995;92:5520-4.
47. Drake CG, Babcock SK, Palmer E, Kotzin BL. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW)F1 mice. Proc Natl Acad Sci USA 1994;91:4062-6.
48. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNFα and TNFβ by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224-31.
49. Turner DM, Grant SCD, Lamb WR, et al. A genetic marker of high TNFα production in heart transplant recipients. Transplantation 1995;60:1113-7.